Who owns CHINA SXT PHARMACEUTICALS IN?
- Ticker: SXTC
- CUSIP Number: g2161p157
Tip: Access positions for across all investors
Analyze quarterly positions in China Sxt Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of China Sxt Pharmaceuticals In stock
Who bought or sold CHINA SXT PHARMACEUTICALS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invesco | 90k | $141k | 100% | Sep 2025 |
|
| Geode Capital Management | 54k | $85k | 100% | Sep 2025 |
|
| Citadel Advisors | 49k | $78k | 100% | Sep 2025 |
|
| Renaissance Technologies | 45k | $70k | 100% | Sep 2025 |
|
| Virtu Financial | 29k | $46k | 107% | Sep 2025 |
|
| Hrt Financial | 27k | $42k | 100% | Sep 2025 |
|
| Two Sigma Securities | 15k | $24k | 100% | Sep 2025 |
|
| Tower Research Capital | 2.9k | $4.5k | 1806% | Sep 2025 |
|
| UBS Group | 100.00 | $200.000000 | -100% | Sep 2025 |
|
| State of Wyoming | 89.00 | $141.999500 | 100% | Sep 2025 |
|